EPO Patents = 3

Trademarks = 2

Forward Citations = 19

Loading Chart...

7 inventors (with patents filed for the assignee):

Casey Cameron McComas (8 out of 42 patents)

Joseph P Vacca (8 out of 110 patents)

Alfredo C Castro (6 out of 114 patents)

4. Tyler Maclay (5 out of 5 patents)

5. Jean-Marc Lapierre (2 out of 34 patents)

6. Melinda Day (2 out of 2 patents)

7. Kevin Mills (2 out of 2 patents)

8 patents: Sort by Forward Citations

1. 12064419 - Methods of using RAD51 inhibitors for treatment of pancreatic cancer (2024-08-20),

2. 11932636 - RAD51 inhibitors (2024-03-19),

3. 11607404 - Combinations of RAD51 and PARP inhibitors (2023-03-21),

4. 11291655 - RAD51 inhibitors (2022-04-05),

5. 11247988 - RAD51 inhibitors (2022-02-15),

6. 11084812 - RAD51 inhibitors (2021-08-10),

7. 10590122 - RAD51 inhibitors (2020-03-17),

8. 10336746 - RAD51 inhibitors (2019-07-02),

Company Overview

Cyteir Therapeutics, Inc. is a biotechnology company focused on developing novel therapeutics for cancer and autoimmune diseases. Their innovative approach targets the DNA repair pathway to selectively eliminate diseased cells while sparing healthy ones. With a promising pipeline of drug candidates and a team of experienced researchers, Cyteir is poised to make a significant impact in the field of precision medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#74 in Lexington, MA

#2,101 in Massachusetts

#35,941 in US

Lexington, MA, United States of America

Cyteir Therapeutics, Inc.

Forward Citations = 19

7 inventors:

Casey Cameron McComas (8 out of 42 patents)

Joseph P Vacca (8 out of 110 patents)

Alfredo C Castro (6 out of 114 patents)

4. Tyler Maclay (5 out of 5 patents)

5. Jean-Marc Lapierre (2 out of 34 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cyteir Therapeutics, Inc.. Retrieved from https://idiyas.com/company/cyteir-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]